Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 8OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8Breast 5Dermatologic 4Head & Neck 3Sarcoma 2Thoracic 1Myeloid 1Lymphoid 1Gynecologic 1Endocrine 1Classical hematology 1CNS 1

Conditions

Ovarian Neoplasms 1773Uterine Cervical Neoplasms 1499Endometrial Neoplasms 833Breast Neoplasms 434Carcinoma, Ovarian Epithelial 405Fallopian Tube Neoplasms 399Uterine Cervical Dysplasia 276Neoplasms 252Colorectal Neoplasms 179Uterine Neoplasms 173Peritoneal Neoplasms 170Vulvar Neoplasms 155Lung Neoplasms 150Pancreatic Neoplasms 141Prostatic Neoplasms 135Recurrence 128Stomach Neoplasms 126Colonic Neoplasms 116Papillomavirus Infections 115Melanoma 101Sarcoma 97Urinary Bladder Neoplasms 95Vaginal Neoplasms 93Carcinoma, Non-Small-Cell Lung 92Head and Neck Neoplasms 91Neoplasm Metastasis 83Esophageal Neoplasms 82Testicular Neoplasms 80Rectal Neoplasms 71Kidney Neoplasms 62

Interventions

inavolisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hereditary Sensory and Autonomic Neuropathies × Gynecologic × Clear all
NCT07522697 2026-04-13

MITO END-4

National Cancer Institute, Naples

Phase 2 Not yet recruiting
48 enrolled
Gynecologic

Hereditary Sensory and Autonomic Neuropathies, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡